Literature DB >> 11059748

A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.

S L Winsey1, N A Haldar, H P Marsh, M Bunce, S E Marshall, A L Harris, F Wojnarowska, K I Welsh.   

Abstract

Exposure to UV radiation is a major risk factor for the development of malignant melanoma. DNA damage caused by UV radiation is thought to play a major role in carcinogenesis induction. Multiprotein pathways involved in repairing UV-DNA damage are the base excision, the nucleotide excision, and the homologous double-stranded DNA repair pathways. This study used a sequence-specific primer PCR (PCR-SSP) genotyping method to investigate the association between polymorphisms in DNA repair genes from these pathways with the development of malignant melanoma. The patient cohort was comprised of 125 individuals with malignant melanoma with lesions or staging suggesting a high risk of relapse or metastatic disease. The control population consisted of 211 individuals. We found the presence of a T allele in exon 7 (position 18067) of the XRCC3 gene was significantly associated with melanoma development (P = 0.004; odds ratio, 2.36; relative risk, 1.74). This gene codes for a protein involved in the homologous pathway of double-stranded DNA repair, thought to repair chromosomal fragmentation, translocations, and deletions. These results may provide further insights into the pathogenesis and the mechanism of UV-radiation induced carcinogenesis as well as having a role in prevention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059748

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells.

Authors:  Takashi Yoshihara; Mari Ishida; Aiko Kinomura; Mari Katsura; Takanori Tsuruga; Satoshi Tashiro; Toshimasa Asahara; Kiyoshi Miyagawa
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

2.  No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.

Authors:  Fatima Zohra Moghtit; Meriem Samia Aberkane; Valérie Le Morvan; Lotfi Louhibi; Ricardo Bellot; Abdelkader Bousahba; Ahlem Megaiz; Mostefa Fodil; Sounnia Mediene-Benchekor; Faouzia Zemani-Fodil; Abdallah Boudjema; Jacques Robert; Nadhira Saidi-Mehtar
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

3.  Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism.

Authors:  Manjari Kundu; Pritha Ghosh; Sanhita Mitra; J K Das; T J Sau; Saptarshi Banerjee; J Christopher States; Ashok K Giri
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

4.  XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids.

Authors:  Ganesh Nagaraju; Andrea Hartlerode; Amy Kwok; Gurushankar Chandramouly; Ralph Scully
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

5.  RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

6.  Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis.

Authors:  Qian Cui; Xiao-Yu Zuo; Yi-Fan Lian; Qi-Sheng Feng; Yun-Fei Xia; Cai-Yun He; Li-Zhen Chen; Wei-Hua Jia; Hai-Qiang Mai; Yi-Xin Zeng; Jin-Xin Bei
Journal:  Tumour Biol       Date:  2016-09-17

7.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

8.  XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; Robert A Wolff; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

9.  Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.

Authors:  Yuhao Dong; Le Zhuang; Weiyuan Ma
Journal:  Tumour Biol       Date:  2013-02-03

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.